Article Information
History
- December 23, 2021.
Article Versions
- Version 1 (September 30, 2021 - 08:49).
- Version 2 (October 1, 2021 - 00:38).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Keli N. Gerken1,
- A. Desirée LaBeaud1,
- Henshaw Mandi2,
- Maïna L’Azou Jackson3,
- J. Gabrielle Breugelmans2 and
- Charles H. King4,*
- 1Division of Pediatric Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA
- 2Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway
- 3Coalition for Epidemic Preparedness Innovations (CEPI), London, UK
- 4Center for Global Health and Diseases, Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
- ↵*Corresponding author: Email: charlesking48{at}gmail.com (CHK)
Posted December 23, 2021.
Paving the way for human vaccination against Rift Valley fever virus: A systematic literature review of RVFV epidemiology from 1999 to 2021
